Spark Therapeutics
Corporate Bias Rating
Expand Summary
Risk Level:
Summary:
Spark Therapeutics is Lower Risk. The company does not yield to political activism in shaping corporate governance, preventing initiatives that potentially alienate consumers, divide employees, and harm shareholders. The company implements race and identity-based policies that replace merit, excellence, and integrity with preferential treatment and outcomes. Overall, Spark Therapeutics does not embrace corporate initiatives that redirect its central focus from business goals to partisan policies and divisive issues. This approach protects free exercise, free speech, and free enterprise.
View Full Corporate Bias Ratings ReportHas canceled customers, suppliers, or vendors due to their political views or religious beliefs OR corporately boycotts, divests, or sanctions regions, people groups, or industries.
Spark Therapeutics received a score of 35 on the 2025 Corporate Equality Index (CEI) from the Human Rights Campaign (HRC), a political stakeholder group. The company recruits employees based on sexual identity issues. The company discriminates against vendors that do not promote divisive sex and gender policies, indicating it prioritizes sexual issues over merit (1)(2). However, Spark Therapeutics has not publicly canceled customers, suppliers, or vendors based on political views or religious beliefs (3).
Charitable giving (including employee matching programs) policies or practices discriminate against charitable organizations based on views or religious beliefs.
Spark Therapeutics will not fund, “projects with a connection to religious, political, commercial or image-building purposes (1).
Employment policies fail to protect against viewpoint or other discrimination and/or are ideological in nature.
Spark Therapeutics does not provide viewpoint protections for its employees (1).
Uses corporate reputation to support causes, organizations, or policies hostile to freedom of expression.
Spark Therapeutics has not supported ideological causes or policies (1).
Uses corporate funds to advance ideological causes, organizations, or policies hostile to freedom of expression.
Spark Therapeutics has not used corporate funds to advance ideological causes, organizations, or policies (1).
Board Bias
Expand Summary
1792 Exchange has not yet compiled data about the board of directors or political contributions of leadership for this company.